ORGANIZATION

Bayer Yakuhin Chief Prinz Named Vice Chairman of EFPIA Japan

September 3, 2018
Bayer Yakuhin President Heike Prinz was appointed vice chairman of the European Federation of Pharmaceutical Industries and Associations (EFPIA), Japan, effective September 1. A German native, Ms Prinz is taking over the role from GlaxoSmithKline’s Philippe Fauchet, who left the…

To read the full story

ORGANIZATION

Takeda Pharmaceutical CEO Christophe Weber highlighted the importance of gaining a strong foothold in the world’s largest pharma market at…

By Reiji Anasako

While generic drugs post solid growth in volume-based shares in Japan, their makers are pondering ways to retool their business…

By Yoshinori Sagehashi

Daiichi Sankyo and GlaxoSmithKline recently announced that they have agreed to dissolve their joint venture company, Japan Vaccine. The failure of this model of joint venture between a major Japanese and foreign drug maker in just six years is disappointing.Over…

By Gregory Ng

To many people, Japan has always been one of the world’s most advanced economies and a market of rich opportunities with one of the top healthcare systems worldwide.Add a rapidly changing demographic, a declining workforce, and the constant challenges of…